Cargando…
Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
BACKGROUND: Osteoprotegerin is a member of the tumor necrosis factor-related family and inhibits RANK stimulation of osteoclast formation as a soluble decoy receptor. The goal of this study was to determine the relationship of serum osteoprotegerin with vascular calcification in patients with type 2...
Autores principales: | Aoki, Atsushi, Murata, Miho, Asano, Tomoko, Ikoma, Aki, Sasaki, Masami, Saito, Tomoyuki, Otani, Taeko, Jinbo, Sachimi, Ikeda, Nahoko, Kawakami, Masanobu, Ishikawa, San-e |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558393/ https://www.ncbi.nlm.nih.gov/pubmed/23302066 http://dx.doi.org/10.1186/1475-2840-12-11 |
Ejemplares similares
-
Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
por: Murata, Miho, et al.
Publicado: (2012) -
Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017) -
Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability
por: Davaine, Jean-Michel, et al.
Publicado: (2014) -
Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic Mice
por: Weiss, Robert M., et al.
Publicado: (2013) -
Calcium and Osteoprotegerin Levels Predict the Progression of the Abdominal Aortic Calcifications After Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2013)